In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting ...
Aug 10, 2011
0
0
Researchers have discovered that exposing people with phobias to their fear—for examples, spiders for those who have arachnophobia—at the exact time their heart beats, led to the phobia reducing in severity.
Oct 30, 2018
1
22
(HealthDay)—Folks who've had a tough case of COVID-19 shouldn't hit the gym for basketball or an aerobics class without getting checked out by their doctor first, according to the American College for Sports Medicine.
Jan 20, 2022
0
19
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can "fight back" against therapies to biologically correct abnormal heartbeat ...
Dec 20, 2022
0
658
Being taller during the course of a person's lifetime could protect against heart disease and stroke in later life, according to a new University of Bristol-led study. The research, which analyzed height and genetic data ...
Nov 3, 2023
0
0
(HealthDay)—With summer approaching, researchers caution that swimming pools may pose a risk to patients with irregular heartbeats who've received implantable defibrillators.
May 9, 2013
0
0
Atrial fibrillation (AF) is the most common heart rhythm disturbance in the United States and affects 2 to 4 million Americans. It is usually a disease of aging, however it can affect people of all ages -- 1 percent of people ...
Oct 6, 2011
0
1
The Food and Drug Administration has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.
Apr 6, 2016
0
7
Christy Strobel arrived at Arnot Ogden Medical Center to be induced into labor on April 14, 2010. But when she was hooked up to the monitors, all plans changed and Christy was rushed into the operating room for an emergency ...
May 17, 2011
0
0
A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical ...
Oct 1, 2012
0
0
